XML 27 R15.htm IDEA: XBRL DOCUMENT
v3.22.4

Stock-based Compensation and Equity Grants | 3 Months Ended
--- | ---
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract] |
Stock-based Compensation and Equity Grants | Stock-Based Compensation and Equity Grants Stock-based compensation expense Options issued under equity incentive plans were designated as either incentive stock or non-statutory stock options. No option is granted with a term of more than 10 years from the date of grant. Exercisability of option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued shares. As of December 31, 2022, there were 1.4 million shares available for grant under the 2016 Omnibus Equity Incentive Plan. Stock-based compensation expense, shown in the table below, is recorded in general and administrative expenses included in our consolidated statements of operations for the three months ended December 31, 2022 and 2021 as follows (in thousands):
|  |  | 2022 |  | 2021 |  |  |  |
DLH employees (a) |  |  | $ | 372 |  |  | $ | 338 |  |  |  |  |
Non-employee directors (b) |  |  | 180 |  |  | 162 |  |  |  |  |
Total stock option expense |  |  | $ | 552 |  |  | $ | 500 |  |  |  |  |
(a) Included in this amount are equity grants of restricted stock units to Executive Officers, which were issued in accordance with the DLH long-term incentive compensation policy in this fiscal year, and stock option grants to executive officers and non-executive company employees. The restricted stock units totaled 140,404 and 147,431 restricted stock units issued and outstanding at December 31, 2022 and 2021, respectively. (b) Equity grants of restricted stock units were made in accordance with DLH compensation policy for non-employee directors and a total of 58,517 and 53,510 restricted stock units were issued and outstanding at December 31, 2022 and 2021, respectively. Unrecognized stock-based compensation expense Unrecognized stock-based compensation expense is presented in the table below for the three months ended December 31, 2022 and 2021 as follows (in thousands):
|  |  | 2022 |  | 2021
Unrecognized expense for DLH employees (a) |  |  | $ | 4,750 |  |  | $ | 5,592 |
Unrecognized expense for non-employee directors |  |  | 538 |  |  | 486 |
Total unrecognized expense |  |  | $ | 5,288 |  |  | $ | 6,078 |
(a) On a weighted average basis, the unrecognized expense for the three months ended December 31, 2022 is expected to be recognized within the next 3.70 years. Stock option activity for the three months ended December 31, 2022 The aggregate intrinsic value in the table below represents the total pretax intrinsic value (i.e., the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, times the number of shares) that would have been received by the option holders had all option holders exercised their in the money options on those dates. This amount will change based on the fair market value of the Company’s stock.
|  |  |  |  |  |  |  |  |  | (in years) |  |
|  |  |  |  |  |  |  |  |  | Weighted |  |
|  |  |  |  |  |  |  | Weighted |  | Average |  | (in thousands)
|  |  |  |  |  | (in thousands) |  | Average |  | Remaining |  | Aggregate
|  |  |  |  |  | Number of |  | Exercise |  | Contractual |  | Intrinsic
|  |  |  |  |  | Shares |  | Price |  | Term |  | Value
Options outstanding, September 30, 2022 |  |  |  |  |  | 2,392 |  |  | $ | 7.05 |  |  | 5.40 |  | $ | 13,566 |
Exercised |  |  |  |  |  | (250) |  |  | 0.95 |  |  | — |  |  | — |
Cancelled |  |  |  |  |  | (25) |  |  | 8.96 |  |  | — |  |  | — |
Options outstanding, December 31, 2022 |  |  |  |  |  | 2,117 |  |  | $ | 7.74 |  |  | 5.78 |  | $ | 9,913 |
Stock options shares outstanding, vested and unvested for the periods ended as follows (shares in thousands):
|  |  | December 31, |  | September 30, |  |
|  |  | 2022 |  | 2022 |  |  |  |
Vested and exercisable (a) |  |  | 1,892 |  |  | 2,117 |  |  |  |  |
Unvested (b) |  |  | 225 |  |  | 275 |  |  |  |  |
Options outstanding |  |  | 2,117 |  |  | 2,392 |  |  |  |  |
(a) The weighted average exercise price of vested and exercisable shares was $6.74 and $5.86 at December 31, 2022 and September 30, 2022, respectively. Aggregate intrinsic value was approximately $9.9 million and $13.6 million at December 31, 2022 and September 30, 2022, respectively. The weighted average contractual term remaining was 5.4 years and 4.9 years at December 31, 2022 and September 30, 2022, respectively. (b) Certain awards vest upon satisfaction of certain performance criteria.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI https://asc.fasb.org/topic&trid=2228938 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (l) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration